Resonant Clinical Solutions

The supplied evidence does not establish the identity, offerings, ownership, location, or history of a commercial entity named Resonant Clinical Solutions. The provided pages concern Daily Post Nigeria and are unrelated to this subject, so no company-specific claims can be substantiated from them.

• 2026.10.07

  Reported2026.10.07

  Resonant Clinical Solutions and Haier Biomedical launch LX-60T100R natural-refrigerant benchtop centrifuge[1]Resonant Clinical Solutions 与 Haier Biomedical 推出采用天然制冷剂的台式离心机 LX-60T100Rprnasia.com

  Resonant Clinical Solutions and Haier Biomedical jointly launched the LX-60T100R, a benchtop centrifuge designed for clinical trials that uses natural hydrocarbon refrigerant R290 instead of F-gases, cutting refrigerant GWP from over 1,400 to about 3. It reached the market more than two years ahead of key F-gas compliance deadlines in Europe and the US. From now until November 2027, clinical trial sponsors and CROs can buy or lease it exclusively through Resonant in global clinical trial markets outside China; the 220-240 V model is available now and a 110 V model is due in Q1 2027.

Read more

1. 1Resonant Clinical Solutions 与 Haier Biomedical 推出采用天然制冷剂的台式离心机 LX-60T100Rprnasia.com